1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques Bienaime sells 9,000 Shares

December 21, 2012 | About:

CEO of Biomarin Pharmaceutical, Inc. (NASDAQ:BMRN) Jean Jacques Bienaime sells 9,000 shares of BMRN on 12/21/2012 at an average price of $48.57 a share.

Biomarin Pharmaceutical, Inc. has a market cap of $6.15 billion; its shares were traded at around $48.9 with and P/S ratio of 13.2.

This is the annual revenues and earnings per share of BMRN over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of BMRN.


CEO Recent Trades:



  • CEO Jean Jacques Bienaime sold 9,000 shares of BMRN stock on 12/21/2012 at the average price of 48.57. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 0.68% since.
  • CEO Jean Jacques Bienaime sold 5,000 shares of BMRN stock on 12/12/2012 at the average price of 50. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has decreased by 2.2% since.
  • CEO Jean Jacques Bienaime sold 6,000 shares of BMRN stock on 12/10/2012 at the average price of 47.53. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 2.88% since.
  • CEO Jean Jacques Bienaime sold 5,000 shares of BMRN stock on 12/04/2012 at the average price of 47.94. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 2% since.
  • CEO Jean Jacques Bienaime sold 8,000 shares of BMRN stock on 11/16/2012 at the average price of 48.05. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 1.77% since.

This is the insider trade history vs. stock price of BMRN. For the complete insider trading history of BMRN, click here.




Directors and Officers Recent Trades:



  • VP, Human Resources Mark Wood sold 10,415 shares of BMRN stock on 12/17/2012 at the average price of 49.17. Mark Wood owns at least 25,646 shares after this. The price of the stock has decreased by 0.55% since.
  • Director Richard A Meier sold 5,000 shares of BMRN stock on 12/11/2012 at the average price of 49.71. Richard A Meier owns at least 18,650 shares after this. The price of the stock has decreased by 1.63% since.
  • Director Richard A Meier sold 5,000 shares of BMRN stock on 11/29/2012 at the average price of 49.17. Richard A Meier owns at least 18,650 shares after this. The price of the stock has decreased by 0.55% since.
  • SVP, Chief Commercial Of Jeffrey Robert Ajer sold 5,916 shares of BMRN stock on 11/28/2012 at the average price of 48.31. Jeffrey Robert Ajer owns at least 10,570 shares after this. The price of the stock has increased by 1.22% since.
  • VP, Human Resources Mark Wood sold 2,665 shares of BMRN stock on 11/23/2012 at the average price of 48.92. Mark Wood owns at least 32,364 shares after this. The price of the stock has decreased by 0.04% since.


For the complete insider trading history of BMRN, click here.
  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership

About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 2.0/5 (2 votes)

Comments

Please leave your comment:


Select portfolio(s):

  • Loading...

Why you are interested?

Your selection and notes will be stored in your portfolio.

Login to add portfolio
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK